Tuesday, November 25, 2014

The agreement, one of the most expensive in the history of the United States against a healthcare c


He onion garlic: come with me always nice. I see the issue of Risperidone and, even when praying with folded hands, fingers escape me running these keyboards God. In Spain there are many things to change. Not for me to dare to do such inventory. However, I think it correct to say that we all want to be well informed. This desire is not easy to achieve, since in many cases the news that tells us is precisely orange julep what deceives us. Even the person who seems disinterested is garlic. And no more garlic autism in Cuenca. Lightly orange julep forget that after a news related to the pharmaceutical world there is never an innocent hand and even less disinterested. The two versions of the same event resulting in two very different stories. See if you find differences. orange julep
J & J will pay a fine of 1,600 million euros for improper promotion of several drugs The drug has been fined for criminal conduct and violation of civil code Promoted for years medicines for purposes other than those approved by the FDA also bribed pharmacists orange julep and physicians to prescribiesen products
The multinational Johnson & Johnson has agreed Monday with the Department of Justice US to pay a fine of more than 2,200 million dollars (about 1.627 million euros) for promoting Risperdal and two other drugs for different uses for which they were authorized .
The agreement, one of the most expensive in the history of the United States against a healthcare company for fraud, involves the payment orange julep of fines for criminal conduct and violation of civil code.
The charges relate to "the orange julep promotion of unapproved uses as safe and effective by the agency that regulates medicines in the US, the FDA, and the payment of bribes to pharmacists and physicians to prescribiesen Risperdal, Invega and Natrecor for these indications "the statement said.
Specifically, the conduct complained of by the Department of Justice affects two drugs used to treat schizophrenia (Risperdal and Invega) and other heart problems (Natrecor), which in some cases were promoted for other uses not approved by the Administration Food and Drug Administration (FDA).
Risperdal hit the market in 1994. Among its side effects, has been linked with excessive weight gain, increased risk of diabetes, stroke and death in elderly and dementia. The FDA approved it in 1993 for psychotic disorders such as schizophrenia. The unit of J & J, Janssen, attempted to increase their market orange julep and promoted for bipolar disorder, dementia, mood disorders and anxiety. Moreover J & J paid between 1990 and 2009 bribes to doctors to prescribe and recommend their medications.
"The conduct alleged in this case has endangered the salu dy patient safety," said US Attorney orange julep General Eric Holder. Because the company had promoted the drug as a therapy for older people with dementia, a use not approved by regulators, and for children before the FDA approved first use in pediatrics in 2006.
The US government has been investigating Risperdal marketing practices since 2004. In April 2011, the company was fined 829 million euros to hide the risks of this drug, and although announced it would appeal the judgment, in August 2011, reached an agreement to resolve other criminal orange julep charges.
The agreement is one of the most substantial ever conducted against health fraud in America. In addition, the company agrees to participate in a program for monitoring and auditing to prevent further unlawful behavior intended orange julep to increase the sale of drugs, which for Holder increases the cost of public health programs such as Medicare or Medicaid.
In recent years, Johnson & Johnson has received numerous lawsuits filed by patients who suffer from gynecomastia as a result of taking Risperdal. Gynecomastia is the growth of breast tissue in male patients. This usually occurred in men who started taking Risperdal in childhood or adolescence. orange julep Other arguments were also presented, in relation to serious side effects, including tardive dyskinesia and neuroleptic malignant orange julep syndrome. orange julep The State of South Carolina vs Johnson & Johnson
In response orange julep to the demands on Risperdal, Judge Roger Couch Circuit Court of SC Johnson & Johnson ordered to pay a total of $ 327 million in closing costs. After hearing the prosecution and the defense, the jury found Johnson & Johnson was guilty of hiding deliberadame

No comments:

Post a Comment